Paul Alain Tagnouokam Ngoupo

Centre de Recherche sur les Maladies Emergentes et Reemergentes (CREMER)/Institut de Recherches Médicales et d’Etudes des Plantes Médicinales (IMPM)

Collaboration Interests
  • Characterisation of HIV circulating strains
  • HIV drug resistance
  • HIV/TB co-infections

Paul Alain Tagnouokam Ngoupo specialised in Biochemistry (BSc), Medical Microbiology (MS) and HIV research. He completed his PhD studies in Virology in 2017 jointly in France and Cameroon. Besides describing the diverse HIV-1 strains circulating in Cameroon, his study also showed that an individual can become infected with two different HIV-1 viruses and give rise to a recombinant virus. After completing his PhD studies, he was recruited as Research Scientist into the HIV research group at Centre Pasteur of Cameroon (CPC) where he currently works.

His research and training activities focus on molecular biology and immunology. His research focuses mainly on HIV (characterisation of circulating strains, resistance, evaluation of laboratory tools, immunology, and mechanisms of HIV control). In his role on the immunology core facility, he contributes to studies on other infectious diseases including tuberculosis (improving biological diagnosis and management), emerging diseases (multiplex diagnosis and surveillance), and COVID-19 (diagnosis, seroprevalence and genomic surveillance).

SANTHE is an Africa Health Research Institute (AHRI) flagship programme funded by the Science for Africa Foundation through the DELTAS Africa programme; the Bill & Melinda Gates Foundation; Gilead Sciences Inc.; and the Ragon Institute of Mass General, MIT, and Harvard.